Sociedad Americana de Hirudoterapia

Hyperbaric oxygen therapy for patients with hypertension after microsurgery of total scalp avulsion

Retrospective study published in Ann Transl Med (2023)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de evidenciaReferencia del artículo
Evidence: Case reportEnsayos clínicosLiu et al. · Annals of translational medicine, 2023

Abstract

BACKGROUND: Total ear avulsion is one of the most serious auricular traumas. Its surgical procedure is complicated and involves high technical difficulty. The auricular blood vessels mostly contain capillaries, and capillary anastomosis reconstruction is difficult. Right ear vascular anastomosis and auricle replantation under microscope are very few cases of successful replantation of total ear avulsion. The lack of blood supply in the amputated ear leads to postoperative blood supply disturbance. At present, there are no reports on the application of hyperbaric oxygen therapy following the replantation of severed ears. Hyperbaric oxygen therapy was used to promote the recovery of vascular microcirculation, reduce complications and improve the survival rate of postoperative ear transplantation. CASE DESCRIPTION: We present a rare case of total ear avulsion in a 53-year-old Chinese man. The patient complained of cutting injury of the right auricle for more than 1 hour. The patient had a history of hypertension for 4 years, and his blood pressure was well controlled by regular administration of valsartan. This paper reports on the treatment experience in a case of microscope-assisted auricular replantation, targeted postoperative treatment, early intervention with hyperbaric oxygen therapy, and individualized nursing care. After 16 days of careful treatment, the patient's avulsion ear survived and he was discharged from the hospital. After 6 months of continuous follow-up, the auricular shape and hearing of the patient reached the ideal standard. CONCLUSIONS: Precise medical and nursing cooperation coupled with meticulous management of the patient throughout the entire process are key factors for the survival of the severed ear. The combined application of microscopic techniques and hyperbaric oxygen therapy improves blood circulation to the anastomosed vessels, accelerates the healing of the replanted ear, and shortens the length of hospital stay. Early hyperbaric oxygen treatment can make postoperative wound heal quickly. Early intervention of hyperbaric oxygen therapy after ear avulsion is helpful to the recovery of patients with ear avulsion. However, the initiation time and duration of intervention need to be further optimized and more evidence is needed to support it.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal Article

Resumen

Retrospective study of hyperbaric-oxygen therapy in hypertensive patients after total scalp avulsion microsurgical replantation.

Por qué esto importa para la hirudoterapia

Este reporte de caso describe a un hombre chino de 53 años con avulsión total de la oreja y antecedente de hipertensión arterial, sometido a reimplante auricular asistido por microscopio seguido de oxigenoterapia hiperbárica temprana. La oreja avulsionada del paciente sobrevivió tras 16 días de tratamiento, con forma auricular y audición satisfactorias en el seguimiento a 6 meses. El resumen se centra en la aplicación combinada de técnicas microquirúrgicas y oxigenoterapia hiperbárica para mejorar la circulación sanguínea y la cicatrización. Para el ámbito de ASH, el artículo carece de toda conexión defendible: las sanguijuelas, la hirudoterapia y el secretoma de la sanguijuela no se mencionan en el resumen. No se presenta ninguna evidencia relativa a la terapia con sanguijuelas.

Citación

Hyperbaric oxygen therapy for patients with hypertension after microsurgery of total scalp avulsion.

Liu et al. · Annals of translational medicine, 2023

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.